Preadmission Use of Calcium Channel Blocking Agents Is Associated with Improved Outcomes in Patients with Sepsis

A Population-Based Propensity Score-Matched Cohort Study

Chien Chang Lee, Meng Tse Gabriel Lee, Wan Chien Lee, Chih Cheng Lai, Christin Chih Ting Chao, Wan Ting Hsu Hsu, Shy Shin Chang, Matthew Lee

研究成果: 雜誌貢獻文章

6 引文 (Scopus)

摘要

Objectives: Use of calcium channel blockers has been found to improve sepsis outcomes in animal studies and one clinical study. This study determines whether the use of calcium channel blockers is associated with a decreased risk of mortality in patients with sepsis. Design: Population-based matched cohort study. Setting: National Health Insurance Research Database of Taiwan. Patients: Hospitalized severe sepsis patients identified from National Health Insurance Research Database by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Interventions: None. Measurements and Main Results: The association between calcium channel blocker use and sepsis outcome was determined by multivariate-adjusted Cox proportional hazard models and propensity score analysis. To examine the influence of healthy user bias, beta-blocker was used as an active comparator. Our study identified 51,078 patients with sepsis, of which, 19,742 received calcium channel blocker treatments prior to the admission. Use of calcium channel blocker was associated with a reduced 30-day mortality after propensity score adjustment (hazard ratio, 0.94; 95% CI, 0.89-0.99), and the beneficial effect could extend to 90-day mortality (hazard ratio, 0.95; 95% CI, 0.89-1.00). In contrast, use of beta-blocker was not associated with an improved 30-day (hazard ratio, 1.06; 95% CI, 0.97-1.15) or 90-day mortality (hazard ratio, 1.00; 95% CI, 0.90-1.11). On subgroup analysis, calcium channel blockers tend to be more beneficial to patients with male gender, between 40 and 79 years old, with a low comorbidity burden, and to patients with cardiovascular diseases, diabetes, or renal diseases. Conclusions: In this national cohort study, preadmission calcium channel blocker therapy before sepsis development was associated with a 6% reduction in mortality when compared with patients who have never received calcium channel blockers.

原文英語
頁(從 - 到)1500-1508
頁數9
期刊Critical Care Medicine
45
發行號9
DOIs
出版狀態已發佈 - 九月 1 2017

指紋

Propensity Score
Calcium Channel Blockers
Calcium Channels
Sepsis
Cohort Studies
Population
Mortality
National Health Programs
Databases
International Classification of Diseases
Taiwan
Proportional Hazards Models
Research
Comorbidity
Cardiovascular Diseases
Kidney
Therapeutics

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

引用此文

Preadmission Use of Calcium Channel Blocking Agents Is Associated with Improved Outcomes in Patients with Sepsis : A Population-Based Propensity Score-Matched Cohort Study. / Lee, Chien Chang; Lee, Meng Tse Gabriel; Lee, Wan Chien; Lai, Chih Cheng; Chao, Christin Chih Ting; Hsu, Wan Ting Hsu; Chang, Shy Shin; Lee, Matthew.

於: Critical Care Medicine, 卷 45, 編號 9, 01.09.2017, p. 1500-1508.

研究成果: 雜誌貢獻文章

Lee, Chien Chang ; Lee, Meng Tse Gabriel ; Lee, Wan Chien ; Lai, Chih Cheng ; Chao, Christin Chih Ting ; Hsu, Wan Ting Hsu ; Chang, Shy Shin ; Lee, Matthew. / Preadmission Use of Calcium Channel Blocking Agents Is Associated with Improved Outcomes in Patients with Sepsis : A Population-Based Propensity Score-Matched Cohort Study. 於: Critical Care Medicine. 2017 ; 卷 45, 編號 9. 頁 1500-1508.
@article{0b8a6fe633474e5982d64612f5ecc2b7,
title = "Preadmission Use of Calcium Channel Blocking Agents Is Associated with Improved Outcomes in Patients with Sepsis: A Population-Based Propensity Score-Matched Cohort Study",
abstract = "Objectives: Use of calcium channel blockers has been found to improve sepsis outcomes in animal studies and one clinical study. This study determines whether the use of calcium channel blockers is associated with a decreased risk of mortality in patients with sepsis. Design: Population-based matched cohort study. Setting: National Health Insurance Research Database of Taiwan. Patients: Hospitalized severe sepsis patients identified from National Health Insurance Research Database by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Interventions: None. Measurements and Main Results: The association between calcium channel blocker use and sepsis outcome was determined by multivariate-adjusted Cox proportional hazard models and propensity score analysis. To examine the influence of healthy user bias, beta-blocker was used as an active comparator. Our study identified 51,078 patients with sepsis, of which, 19,742 received calcium channel blocker treatments prior to the admission. Use of calcium channel blocker was associated with a reduced 30-day mortality after propensity score adjustment (hazard ratio, 0.94; 95{\%} CI, 0.89-0.99), and the beneficial effect could extend to 90-day mortality (hazard ratio, 0.95; 95{\%} CI, 0.89-1.00). In contrast, use of beta-blocker was not associated with an improved 30-day (hazard ratio, 1.06; 95{\%} CI, 0.97-1.15) or 90-day mortality (hazard ratio, 1.00; 95{\%} CI, 0.90-1.11). On subgroup analysis, calcium channel blockers tend to be more beneficial to patients with male gender, between 40 and 79 years old, with a low comorbidity burden, and to patients with cardiovascular diseases, diabetes, or renal diseases. Conclusions: In this national cohort study, preadmission calcium channel blocker therapy before sepsis development was associated with a 6{\%} reduction in mortality when compared with patients who have never received calcium channel blockers.",
keywords = "calcium channel blocker, pharmacoepidemiology, population-based cohort study, propensity score, sepsis outcome",
author = "Lee, {Chien Chang} and Lee, {Meng Tse Gabriel} and Lee, {Wan Chien} and Lai, {Chih Cheng} and Chao, {Christin Chih Ting} and Hsu, {Wan Ting Hsu} and Chang, {Shy Shin} and Matthew Lee",
year = "2017",
month = "9",
day = "1",
doi = "10.1097/CCM.0000000000002550",
language = "English",
volume = "45",
pages = "1500--1508",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Preadmission Use of Calcium Channel Blocking Agents Is Associated with Improved Outcomes in Patients with Sepsis

T2 - A Population-Based Propensity Score-Matched Cohort Study

AU - Lee, Chien Chang

AU - Lee, Meng Tse Gabriel

AU - Lee, Wan Chien

AU - Lai, Chih Cheng

AU - Chao, Christin Chih Ting

AU - Hsu, Wan Ting Hsu

AU - Chang, Shy Shin

AU - Lee, Matthew

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Objectives: Use of calcium channel blockers has been found to improve sepsis outcomes in animal studies and one clinical study. This study determines whether the use of calcium channel blockers is associated with a decreased risk of mortality in patients with sepsis. Design: Population-based matched cohort study. Setting: National Health Insurance Research Database of Taiwan. Patients: Hospitalized severe sepsis patients identified from National Health Insurance Research Database by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Interventions: None. Measurements and Main Results: The association between calcium channel blocker use and sepsis outcome was determined by multivariate-adjusted Cox proportional hazard models and propensity score analysis. To examine the influence of healthy user bias, beta-blocker was used as an active comparator. Our study identified 51,078 patients with sepsis, of which, 19,742 received calcium channel blocker treatments prior to the admission. Use of calcium channel blocker was associated with a reduced 30-day mortality after propensity score adjustment (hazard ratio, 0.94; 95% CI, 0.89-0.99), and the beneficial effect could extend to 90-day mortality (hazard ratio, 0.95; 95% CI, 0.89-1.00). In contrast, use of beta-blocker was not associated with an improved 30-day (hazard ratio, 1.06; 95% CI, 0.97-1.15) or 90-day mortality (hazard ratio, 1.00; 95% CI, 0.90-1.11). On subgroup analysis, calcium channel blockers tend to be more beneficial to patients with male gender, between 40 and 79 years old, with a low comorbidity burden, and to patients with cardiovascular diseases, diabetes, or renal diseases. Conclusions: In this national cohort study, preadmission calcium channel blocker therapy before sepsis development was associated with a 6% reduction in mortality when compared with patients who have never received calcium channel blockers.

AB - Objectives: Use of calcium channel blockers has been found to improve sepsis outcomes in animal studies and one clinical study. This study determines whether the use of calcium channel blockers is associated with a decreased risk of mortality in patients with sepsis. Design: Population-based matched cohort study. Setting: National Health Insurance Research Database of Taiwan. Patients: Hospitalized severe sepsis patients identified from National Health Insurance Research Database by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Interventions: None. Measurements and Main Results: The association between calcium channel blocker use and sepsis outcome was determined by multivariate-adjusted Cox proportional hazard models and propensity score analysis. To examine the influence of healthy user bias, beta-blocker was used as an active comparator. Our study identified 51,078 patients with sepsis, of which, 19,742 received calcium channel blocker treatments prior to the admission. Use of calcium channel blocker was associated with a reduced 30-day mortality after propensity score adjustment (hazard ratio, 0.94; 95% CI, 0.89-0.99), and the beneficial effect could extend to 90-day mortality (hazard ratio, 0.95; 95% CI, 0.89-1.00). In contrast, use of beta-blocker was not associated with an improved 30-day (hazard ratio, 1.06; 95% CI, 0.97-1.15) or 90-day mortality (hazard ratio, 1.00; 95% CI, 0.90-1.11). On subgroup analysis, calcium channel blockers tend to be more beneficial to patients with male gender, between 40 and 79 years old, with a low comorbidity burden, and to patients with cardiovascular diseases, diabetes, or renal diseases. Conclusions: In this national cohort study, preadmission calcium channel blocker therapy before sepsis development was associated with a 6% reduction in mortality when compared with patients who have never received calcium channel blockers.

KW - calcium channel blocker

KW - pharmacoepidemiology

KW - population-based cohort study

KW - propensity score

KW - sepsis outcome

UR - http://www.scopus.com/inward/record.url?scp=85021441322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021441322&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000002550

DO - 10.1097/CCM.0000000000002550

M3 - Article

VL - 45

SP - 1500

EP - 1508

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 9

ER -